COCRYSTAL PHARMA, INC. Proceeds from Secured Notes Payable
COCRYSTAL PHARMA, INC. (COCP) reported Proceeds from Secured Notes Payable of $2.63 million for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromSecuredNotesPayable · last filed 2016-11-09
- 2014-09-30: Proceeds from Secured Notes Payable 1 month $2.63M; Proceeds from Secured Notes Payable 9 month $2.63M.
- 2014-06-30: Proceeds from Secured Notes Payable 1 month $2.63M; Proceeds from Secured Notes Payable 1 month as first filed $2.63M.
| Period end | Proceeds from Secured Notes Payable 1 month | Proceeds from Secured Notes Payable 1 month as first filed | Proceeds from Secured Notes Payable 9 month |
|---|---|---|---|
| 2014-09-30 | $2.63M 10-Q · filed 2016-11-09 | $2.63M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $2.63M 10-Q · filed 2016-08-09 | $2.63M 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |